Glioblastoma multiforme

New Study Investigates Anti-Angiogenic Viral Gene Therapy

Published in Gene Therapy Weekly, July 5th, 2001

The University of Arizona College of Medicine has been selected as the first site in the United States for an exciting new research study that will use viral gene delivery to treat patients diagnosed with difficult-to-treat glioblastoma multiform (GBM) brain tumors.

Beginning in January 2002, researchers will inject trillions of non-replicating virus cells containing the beta interferon gene directly into the tumors of patients, says Allan J. Hamilton, MD, FACS, head of the Department of Surgery at the UA College of Medicine. The virus will deliver the gene to the tumor cells causing the cells to produce beta interferons. Interferons are naturally-occurring proteins...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2001-07-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry